Better Therapeutics : Results of Operations and Financial Condition - Form 8-K

Item 2.02 Results of Operations and Financial Condition.

On October 27, 2023, Better Therapeutics, Inc. (the "Company") disclosed in its registration statement on Form S-1(File No. 333-268706)that its previously reported financial statements include a payroll accrual of $1.5 million related to expenses incurred during 2022. The Company's management has determined that this payroll accrual will not be paid out and therefore plans to reverse such amount in its financial statements for the quarter ended September 30, 2023.

The information contained in Item 2.02 in this Current Report on Form 8-Kis intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.